ERIBULIN MESYLATE | A214850 | LONG GROVE PHARMACEUTICALS LLC
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
Attachment 2 - HALAVEN- eribulin mesylate injection RE Suitability Petition f... FDA-2023-P-5135 · 7 docket documents Hyman, Phelps & McNamara, P.C. filed a suitability petition regarding HALAVEN (eribulin mesylate injection), requesting FDA evaluation of the product's suitability for regulatory purposes under applicable standards. | Suitability | 2023-11-20 | Granted | Hyman, Phelps & McNamara, P.C. |
Source: Regulations.gov. FDA citizen petitions matched by application number.
No patent or exclusivity listings for this strength.